Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
D002318:Cardiovascular Diseases / Q000139:chemically induced; D008076:Cholesterol, HDL / Q000097:blood; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D017135:Desogestrel; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D008074:Lipoproteins / Q000097:blood*; D009640:Norethindrone / Q000008:administration & dosage / Q000009:adverse effects; D009644:Norgestrel / Q000008:administration & dosage / Q000009:adverse effects; D009652:Norpregnenes / Q000008:administration & dosage / Q000009:adverse effects; D011159:Population Surveillance; D045167:Progesterone Congeners / Q000009:adverse effects*; D011446:Prospective Studies; D012306:Risk
D008076:Cholesterol, HDL; D003280:Contraceptives, Oral, Synthetic; D008074:Lipoproteins; D009652:Norpregnenes; D045167:Progesterone Congeners; D009644:Norgestrel; D016912:Levonorgestrel; D017135:Desogestrel; D009640:Norethindrone